PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions

Agios Pharmaceuticals, Inc. (AGIO)

Equity · Currency in USD · Last updated Nov 25, 2023
SummaryFinancials

Company Info

ISINUS00847X1046
CUSIP00847X104
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$1.25B
EPS-$3.94
Revenue (TTM)$24.03M
Gross Profit (TTM)$12.54M
EBITDA (TTM)-$377.35M
Year Range$19.80 - $31.87
Target Price$38.00
Short %10.25%
Short Ratio8.91

Share Price Chart


Loading data...

Performance

The chart shows the growth of an initial investment of $10,000 in Agios Pharmaceuticals, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%50.00%100.00%150.00%JuneJulyAugustSeptemberOctoberNovember
24.06%
169.27%
AGIO (Agios Pharmaceuticals, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with AGIO

Agios Pharmaceuticals, Inc.

Popular comparisons: AGIO vs. VEXMX, AGIO vs. MO, AGIO vs. PFE

Return

Agios Pharmaceuticals, Inc. had a return of -20.48% year-to-date (YTD) and -22.55% in the last 12 months. Over the past 10 years, Agios Pharmaceuticals, Inc. had an annualized return of 2.63%, while the S&P 500 had an annualized return of 9.74%, indicating that Agios Pharmaceuticals, Inc. did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date-20.48%18.75%
1 month10.65%8.90%
6 months-13.52%8.42%
1 year-22.55%13.21%
5 years (annualized)-19.10%11.63%
10 years (annualized)2.63%9.74%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2023-0.44%10.54%12.03%-6.36%3.43%-9.77%-15.11%

Risk-Adjusted Performance

This table presents a comparison of risk-adjusted performance metrics for Agios Pharmaceuticals, Inc. (AGIO) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
AGIO
Agios Pharmaceuticals, Inc.
-0.59
^GSPC
S&P 500
0.98

Sharpe Ratio

The current Agios Pharmaceuticals, Inc. Sharpe ratio is -0.59. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-0.500.000.501.00JuneJulyAugustSeptemberOctoberNovember
-0.59
1.05
AGIO (Agios Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Dividend History


Agios Pharmaceuticals, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-83.46%
-5.28%
AGIO (Agios Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Agios Pharmaceuticals, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Agios Pharmaceuticals, Inc. was 87.36%, occurring on Jun 14, 2022. The portfolio has not yet recovered.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-87.36%Jan 15, 20151866Jun 14, 2022
-51.6%Oct 7, 201336Nov 25, 201333Jan 14, 201469
-38.02%Jan 16, 201412Feb 3, 201423Mar 7, 201435
-34.2%Apr 10, 201428May 20, 201422Jun 20, 201450
-32.91%Jun 23, 201418Jul 17, 201448Sep 24, 201466

Volatility Chart

The current Agios Pharmaceuticals, Inc. volatility is 13.64%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%JuneJulyAugustSeptemberOctoberNovember
13.64%
3.39%
AGIO (Agios Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Recent discussions